A) NF-kB Pathway: Cancer cells in particular, cancer stem cells (CSCs) and cancer resistant cells (CRCs) desensitize themselves to intervention by activating several survival pathways (e.g. NF-kB, PARP) and downregulating cell death pathways (e.g. CD95). This evidence concerns the gene NFKB1 and cancer.